Integer Holdings Corporation (NYSE:ITGR) Holdings Increased by Laurus Global Equity Management Inc.

Laurus Global Equity Management Inc. increased its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 16.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,770 shares of the medical equipment provider's stock after purchasing an additional 6,855 shares during the quarter. Integer makes up approximately 3.8% of Laurus Global Equity Management Inc.'s holdings, making the stock its 9th biggest holding. Laurus Global Equity Management Inc. owned approximately 0.14% of Integer worth $5,637,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in ITGR. Lee Danner & Bass Inc. bought a new position in shares of Integer in the 4th quarter valued at about $27,000. Opal Wealth Advisors LLC acquired a new position in Integer during the first quarter valued at approximately $28,000. AdvisorNet Financial Inc acquired a new position in Integer during the first quarter valued at approximately $28,000. Bessemer Group Inc. grew its holdings in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after purchasing an additional 125 shares during the period. Finally, Sterling Capital Management LLC grew its holdings in Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Raymond James Financial upped their price target on shares of Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, April 25th. Wall Street Zen raised shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Benchmark cut their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 25th. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. Two analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $145.00.

Integer Price Performance

ITGR traded down $2.04 during midday trading on Friday, hitting $119.73. The stock had a trading volume of 343,094 shares, compared to its average volume of 388,549. The company has a market cap of $4.18 billion, a P/E ratio of 56.74, a price-to-earnings-growth ratio of 1.05 and a beta of 0.98. The business has a fifty day moving average of $119.85 and a 200 day moving average of $125.07. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40. Integer Holdings Corporation has a 1 year low of $104.93 and a 1 year high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last announced its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. The firm's revenue for the quarter was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.14 earnings per share. As a group, equities analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Integer news, Director Martin C. Maxwell sold 8,720 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director owned 22,170 shares in the company, valued at $2,672,815.20. This trade represents a 28.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares of the company's stock, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 362,434 shares of company stock valued at $44,577,115 over the last ninety days. Company insiders own 2.16% of the company's stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.